Placebo run-in period in studies of depressive disorders: Clinical, heuristic and research implications
The DOI matches its Crossref record.
Abstract
Background: In spite of the virtually ubiquitous nature of the initial 10-day placebo run-in period (IPR) in drug trials, there is little empirical data establishing its relevance. Method: Data from 593 subjects were examined retrospectively to determine whether or not the prognosis of subjects minimally improved during the IPR was different to those who were unimproved. The IPR period was single-blind and was followed by a six-week double-blind phase in all studies. Results: Twenty-six per cent of the subjects were minimally improved and 74% were unimproved. Approximately 10% of the subjects who were much improved were not followed systematically. Across a range of diagnosis, severity and chronicity subjects minimally improved (versus unimproved) after IPR had a more favourable prognosis whether assigned to drug or placebo. Conclusions: Change during IPR appears to be a meaningful predictor. Stratification should be considered in future antidepressant studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Sackeim, H. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00271-8 · Cited by 568
Sleep deprivation in depression: what do we know, where do we go?
Wirz-Justice, A., & Van den Hoofdakker, R. H. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00125-0 · Cited by 429
“A recent metaanalysis of the placebo run-in period revealed that any mood change during this baseline period was a predictor for more favorable prognosis 6 weeks later–whether or not assigned to drug or placebo (Quitkin et al 1998).”
BackgroundChanges in Brain Function of Depressed Subjects During Treatment With Placebo
Leuchter, A. F., Cook, I. A., Witte, E. A., Morgan, M., & Abrams, M. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.122 · Cited by 396
Antidepressants and the placebo effect
Kirsch, I. (2014) · Zeitschrift für Psychologie · doi:10.1027/2151-2604/a000176 · Cited by 164
Coplan, J. D., Gopinath, S., Abdallah, C. G., & Berry, B. R. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00189 · Cited by 90
REM sleep reduction, mood regulation and remission in untreated depression
Cartwright, R., Baehr, E., Kirkby, J., Pandi-Perumal, S. R., & Kabat, J. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(03)00236-1 · Cited by 82
The 2 “Es” of Research: Efficacy and Effectiveness Trials
Streiner, D. L. (2002) · The Canadian Journal of Psychiatry · doi:10.1177/070674370204700607 · Cited by 79
Metadata
- Authors
- Quitkin, F. M., McGrath, P. J., Stewart, J. W., Ocepek-Welikson, K., Taylor, B. P., Nunes, E., Delivannides, D., Agosti, V., Donovan, S. J., Ross, D., Petkova, E., & Klein, D. F.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 1998-09
- Volume
- 173
- Issue
- 3
- Pages
- 242-248
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W2147040098
- Cited by
- 37
- References
- 0
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.